Maria Kallieri

416 total citations
22 papers, 84 citations indexed

About

Maria Kallieri is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Surgery. According to data from OpenAlex, Maria Kallieri has authored 22 papers receiving a total of 84 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 12 papers in Physiology and 4 papers in Surgery. Recurrent topics in Maria Kallieri's work include Asthma and respiratory diseases (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers) and Respiratory and Cough-Related Research (5 papers). Maria Kallieri is often cited by papers focused on Asthma and respiratory diseases (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers) and Respiratory and Cough-Related Research (5 papers). Maria Kallieri collaborates with scholars based in Greece, Germany and France. Maria Kallieri's co-authors include Andriana Ι. Papaioannou, Stelios Loukides, Spyridon Papiris, Polyxeni Ntontsi, Effrosyni D. Manali, Lykourgos Kolilekas, Georgia Papadaki, Sofia Chatziioannou, Philippe Dieudé and Νikoletta Ρovina and has published in prestigious journals such as PLoS ONE, CHEST Journal and Journal of Clinical Medicine.

In The Last Decade

Maria Kallieri

17 papers receiving 80 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maria Kallieri Greece 4 63 62 20 13 7 22 84
Chris Bell United States 4 30 0.5× 44 0.7× 9 0.5× 6 0.5× 16 2.3× 7 72
Gilles Garcia France 1 52 0.8× 80 1.3× 26 1.3× 27 2.1× 19 2.7× 2 105
Moisés Calderón United Kingdom 3 22 0.3× 48 0.8× 21 1.1× 29 2.2× 10 1.4× 5 74
Clementine Bostantzoglou Greece 4 38 0.6× 31 0.5× 3 0.1× 8 0.6× 5 0.7× 12 60
Raj K Rajakulasingam United Kingdom 4 64 1.0× 77 1.2× 23 1.1× 13 1.0× 8 1.1× 7 112
Antonio Perrella Italy 4 45 0.7× 64 1.0× 17 0.8× 12 0.9× 2 0.3× 6 71
В. И. Трофимов Russia 5 58 0.9× 57 0.9× 2 0.1× 24 1.8× 3 0.4× 32 104
Jessica Tantivit United States 2 18 0.3× 33 0.5× 10 0.5× 39 3.0× 10 1.4× 3 67
Yoshihisa Tokunaga Japan 5 38 0.6× 33 0.5× 3 0.1× 19 1.5× 6 0.9× 10 63
Maria Curotto de Lafaille United States 4 19 0.3× 30 0.5× 17 0.8× 13 1.0× 8 1.1× 5 45

Countries citing papers authored by Maria Kallieri

Since Specialization
Citations

This map shows the geographic impact of Maria Kallieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Kallieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Kallieri more than expected).

Fields of papers citing papers by Maria Kallieri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Kallieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Kallieri. The network helps show where Maria Kallieri may publish in the future.

Co-authorship network of co-authors of Maria Kallieri

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Kallieri. A scholar is included among the top collaborators of Maria Kallieri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Kallieri. Maria Kallieri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kallieri, Maria, Andriana Ι. Papaioannou, & Stelios Loukides. (2025). Mepolizumab for severe eosinophilic asthma. Expert Review of Respiratory Medicine. 20(1). 13–25.
2.
Kallieri, Maria, et al.. (2025). COPD and the burden of multimorbidity: navigating the complexity. Expert Review of Respiratory Medicine. 20(3). 251–266.
3.
Tomos, Ioannis, Konstantina Dimakopoulou, Maria Kallieri, et al.. (2025). The prognostic role of lung ultrasound in hospitalised patients with COVID-19. Correlation with chest CT findings and clinical markers of severity. Expert Review of Respiratory Medicine. 19(4). 363–370.
4.
Manali, Effrosyni D., Κonstantinos Thomas, Maria Kallieri, et al.. (2025). Long-Term Lung Sequelae in Survivors of Severe/Critical COVID-19 Pneumonia: The “Non-Steroid”, “Non-Interventional” Approach. Journal of Clinical Medicine. 14(2). 347–347. 2 indexed citations
5.
Kallieri, Maria, Nektarios Koufopoulos, Abraham Pouliakis, et al.. (2024). Sensitization to Staphylococcus Enterotoxin: Relationship with Aspects of Disease Severity. Journal of Clinical Medicine. 13(19). 5836–5836. 1 indexed citations
6.
Papaporfyriou, Anastasia, Maria Kallieri, Aris Spathis, et al.. (2024). Effects of menopause and fat mass in asthmatic inflammation. Journal of Asthma. 61(11). 1488–1496. 1 indexed citations
7.
Papiris, Spyros A., Camille Louvrier, Aurélie Fabre, et al.. (2023). CSF2RBmutation-related hereditary pulmonary alveolar proteinosis: the “long and winding road” into adulthood. ERJ Open Research. 9(6). 703–2023. 3 indexed citations
8.
Papiris, Spyros A., Lykourgos Kolilekas, Natalia V. Rivera, et al.. (2023). From Karl Wurm and Guy Scadding's staging to 18F-FDG PET/CT scan phenotyping and far beyond: perspective in the evading history of phenotyping in sarcoidosis. Frontiers in Medicine. 10. 1174518–1174518. 3 indexed citations
9.
Papiris, Spyros A., Vasiliki Pappa, Maria Kallieri, et al.. (2023). Diffuse panniculitis in a teenage male with ZZ α1-antitrypsin deficiency. ERJ Open Research. 9(2). 546–2022.
10.
Papaioannou, Andriana Ι., Evangelia Fouka, Κonstantinos Bartziokas, et al.. (2023). Defining response to therapy with biologics in severe asthma: from global evaluation to super response and remission. Expert Review of Respiratory Medicine. 17(6). 481–493. 7 indexed citations
11.
Papiris, Spyros A., Maria Kallieri, Lykourgos Kolilekas, et al.. (2023). Autoimmune Pulmonary Alveolar Proteinosis (aPAP) in Greece: 20 years in progress. OA3275–OA3275. 1 indexed citations
12.
Papiris, Spyros A., Caroline Kannengiesser, Raphaël Borie, et al.. (2022). Genetics in Idiopathic Pulmonary Fibrosis: A Clinical Perspective. Diagnostics. 12(12). 2928–2928. 7 indexed citations
13.
Tomos, Ioannis, Maria Kallieri, Andriana Ι. Papaioannou, et al.. (2022). Pulmonary hemorrhage in patients receiving anti-platelets- a case series and a suggested therapeutic algorithm. Respiratory Medicine Case Reports. 40. 101782–101782.
14.
Papaioannou, Andriana Ι., Maria Kallieri, George Papatheodorou, et al.. (2022). Sestrin 2 levels are associated with emphysematous phenotype of COPD. PLoS ONE. 17(8). e0273652–e0273652. 3 indexed citations
15.
Papiris, Spyros A., Effrosyni D. Manali, Andriana Ι. Papaioannou, et al.. (2020). Prevalence, distribution and clinical significance of joints, muscles and bones in sarcoidosis: an 18F-FDG-PET/CT study. Expert Review of Respiratory Medicine. 14(9). 957–964. 3 indexed citations
16.
Papiris, Spyros, Eleni Stagaki, Georgia Papadaki, et al.. (2019). Mycophenolate mofetil as an alternative treatment in sarcoidosis. Pulmonary Pharmacology & Therapeutics. 58. 101840–101840. 13 indexed citations
17.
Mazioti, Argyro, Maria Kallieri, Georgios Papatheodorou, et al.. (2019). SESTRINS IN COPD. CHEST Journal. 155(6). A327–A327. 1 indexed citations
18.
Papaioannou, Andriana Ι., Effrosyni D. Manali, Panagiotis Lyberopoulos, et al.. (2018). The effects of pulmonary rehabilitation in patients with Combined Pulmonary Fibrosis and Emphysema (CPFE). PA4151–PA4151. 1 indexed citations
19.
Stagaki, Eleni, Effrosyni D. Manali, Georgia Papadaki, et al.. (2018). Mycophenalate Mofetil as a corticosteroid- sparing agent in patients with sarcoidosis.. PA4103–PA4103. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chris Bell Breakdown of academic impact, for papers by Gilles Garcia Breakdown of academic impact, for papers by Moisés Calderón Breakdown of academic impact, for papers by Clementine Bostantzoglou Breakdown of academic impact, for papers by Raj K Rajakulasingam Breakdown of academic impact, for papers by Antonio Perrella Breakdown of academic impact, for papers by В. И. Трофимов Breakdown of academic impact, for papers by Jessica Tantivit Breakdown of academic impact, for papers by Yoshihisa Tokunaga Breakdown of academic impact, for papers by Maria Curotto de Lafaille
Rankless by CCL
2026